MEETINGS - BIC (Germany) May 2008
This article was originally published in Clinica
Business in China, a "procurement summit" for European companies wishing to establish or expand their operations in China, will take place during May 28-29 2008 at the Berliner Congress Centre, Berlin, Germany. Among the industries included are medical technology, biotechnology and pharmaceuticals. Delegate numbers are restricted to 800 to ensure that bespoke agendas can be created and addressed for each attendee, says BIC. A conference will run concurrently to provide key aspects of conducting business in China and to highlight the business prospects of some of China's regions. For more information and to register, see: www.businesschinaexpo.com
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.